Isolation of anticancer bioactive secondary metabolites from the sponge-derived endophytic fungi Penicillium sp. and in-silico computational docking approach

Introduction Fungus-derived secondary metabolites are fascinating with biomedical potential and chemical diversity. Mining endophytic fungi for drug candidates is an ongoing process in the field of drug discovery and medicinal chemistry. Endophytic fungal symbionts from terrestrial plants, marine flora, and fauna tend to produce interesting types of secondary metabolites with biomedical importance of anticancer, antiviral, and anti-tuberculosis properties. Methods An organic ethyl acetate extract of Penicillium verruculosum sponge-derived endophytic fungi from Spongia officinalis yielded seven different secondary metabolites which are purified through HPLC. The isolated compounds are of averufin (1), aspergilol-A (2), sulochrin (3), monomethyl sulochrin (4), methyl emodin (5), citreorosein (6), and diorcinol (7). All the seven isolated compounds were characterized by high-resolution NMR spectral studies. All isolated compounds', such as anticancer, antimicrobial, anti-tuberculosis, and antiviral, were subjected to bioactivity screening. Results Out of seven tested compounds, compound (1) exhibits strong anticancer activity toward myeloid leukemia. HL60 cell lines have an IC50 concentration of 1.00μm, which is nearly significant to that of the standard anticancer drug taxol. A virtual computational molecular docking approach of averufin with HL60 antigens revealed that averufin binds strongly with the protein target alpha, beta-tubulin (1JFF), with a −10.98 binding score. Consecutive OSIRIS and Lipinski ADME pharmacokinetic validation of averufin with HL60 antigens revealed that averufin has good pharmacokinetic properties such as drug score, solubility, and mutagenic nature. Furthermore, aspergilol-A (2) is the first report on the Penicillium verruculosum fungal strain. Discussion We concluded that averufin (1) isolated from Penicillium verruculosum can be taken for further preliminary clinical trials like animal model in-vivo studies and pharmacodynamic studies. A future prospect of in-vivo anticancer screening of averufin can be validated through the present experimental findings.

Introduction: Fungus-derived secondary metabolites are fascinating with biomedical potential and chemical diversity.Mining endophytic fungi for drug candidates is an ongoing process in the field of drug discovery and medicinal chemistry.Endophytic fungal symbionts from terrestrial plants, marine flora, and fauna tend to produce interesting types of secondary metabolites with biomedical importance of anticancer, antiviral, and anti-tuberculosis properties.
Results: Out of seven tested compounds, compound ( ) exhibits strong anticancer activity toward myeloid leukemia.HL cell lines have an IC concentration of .µm, which is nearly significant to that of the standard anticancer drug taxol.A virtual computational molecular docking approach of averufin with HL antigens revealed that averufin binds strongly with the protein target alpha, beta-tubulin ( JFF), with a − .binding score.Consecutive OSIRIS and Lipinski ADME pharmacokinetic validation of averufin with HL antigens revealed that averufin has good pharmacokinetic properties such as drug score, solubility, and mutagenic nature.Furthermore, aspergilol-A ( ) is the first report on the Penicillium verruculosum fungal strain.

Discussion:
We concluded that averufin ( ) isolated from Penicillium verruculosum can be taken for further preliminary clinical trials like animal model in-vivo studies and pharmacodynamic studies.A future prospect for their immense pharmacological importance may endanger their community, an effective and alternate method of trapping such endophytes and culturing them in laboratory conditions may yield the targeted secondary metabolites on a pilot scale.
Spongia officinalis is a marine sponge that has been used for bioprospecting for many years.An interesting class of chemical moieties like furanosesterpenes and scalarene sesquiterpenes with antibacterial and anticancer properties were isolated from Spongia officinalis (Manzo et al., 2011).Whether these bioactive compounds are produced by host organisms or from their endophytic symbionts is a topic of debate.As an ongoing attempt of our continuous exploration for bioactive compounds from the spongederived endophytes (Yang et al., 2009;Sun et al., 2015;Wang et al., 2015a), we isolated a fungal strain Penicillium verruculosum (XWSO1F60) derived from a marine sponge Spongia officinalis.The fungus was fermented on a large scale and extracted, and its bioactive compound isolation was conducted through chromatographic purification, like HPLC.Structural elucidation of isolated compounds was carried out through NMR spectroscopic studies.Herein, we have reported on the fermentation, extraction, and isolation strategies of those bioactive metabolites.
. Materials and methods

. . General experimental procedures
NMR studies were recorded on a Bruker AC 500MHz NMR (Bruker, Fällanden, Switzerland) spectrometer using TMS as an internal standard.Chemical shifts were expressed in "d" (ppm) and coupling constant 'J' in Hz.HR-ESI-MS were measured using a Bruker micro TOF-QII mass spectrometer (Bruker, Fällanden, Switzerland).Size exclusion chromatography was conducted using Sephadex LH-20 gel (GE Healthcare, Uppsala, Sweden).Column chromatography was performed using a silica gel (200-300) at Qingdao Marine Chemical Factory (Qingdao, China).TLC spots were detected under UV light and by heating after spraying with 12% H 2 SO4 in H 2 O. Semi-preparative HPLC (RP-HPLC) was conducted on Agilent HPLC (Agilent 1260 infinity series with DAD detector, Santa Clara, CA, USA).All the positive control standard drugs used in the bioassay were procured from Sigma Aldrich (USA).

. . DNA extraction and phylogenetic sequence analysis
The endophytic fungus XWSO1F60 was isolated from the sponge S. officinalis.The strain was grown on a MactoBalt (MB) agar slant at 25 • C. Two-week-old fungal hyphae were scraped for genomic DNA isolation using the Ultraclean Microbial DNA Kit (MoBio Laboratories).The internal transcribed spacer of ribosomal nucleotide sequence (ITS rDNA) primers ITS1 (5 ′ -GCACAGGCAGCAGGAGCTG CCCCTCAGCTGTCTCCTCGTGCTCAAC-3 ′ ) and ITS (5 ′ -AGAGCAAGCCGAGCAGGTCTATCGCCAAGTATCCTCAG AAGCTGTGCT-3 ′ ) were used (Volkov et al., 2014).The PCR reaction was conducted using Eppendorf equipment (Eppendorf, NY, USA).The reaction mixture of 50 µL consisted of polymerase chain reaction (PCR) buffer, 2.5 mM Mg 2+ , 100 µM dNTPs, 0.5 µM each primer, 10 ng extracted DNA, and 2 U Taq polymerase.The thermocycling steps involved an initial denaturation at 95 o C for 5 min, followed by 20 cycles consisting of 1.5 min at 95 o C, 2 min at 50 o C, and 2 min at 68 o C.This was followed by another set of 20 cycles with 10 min at 68 C and a final extension step of 10 min at 4 o C. The resulting PCR product was processed from agarose gel using QIA quick Gel Extraction Kit (QIAGEN, Valencia, CA, USA) and sequenced using an ABI 3730 sequencer (Applied Bio-systems, USA).Sequences were analyzed using the BLAST program (Basic Local Alignment Search Tool).The phylogenetic tree was constructed based on the neighbor-joining (NJ) method using MEGA-5.0 by using 1,000 bootstrap replicates.The sequence was deposited in GenBank and assigned an accession number (Genbank: KU891245).

. . Fermentation, extraction, and isolation of compounds
A stock culture of the strain XWSO1F60 was grown on MB agar solid medium at 25 0 C for a week.The stock culture was inoculated in an optimized seed medium (malt extract 15 g, sea salt 2.5 g, NaCl 2.5 g, distilled water 1000 mL, pH 7.4 −7.8) and incubated at 25 0 C for 72 h on a rotating shaker (180 rpm).The optimization of the growth medium was selected based on previous experimental validation with maximum fungal growth and UV-HPLC metabolite fingerprinting.The mass quantity of fermentation of fungal isolates XWSO1F60 was carried out using a solid rice medium in 1000 mL flasks (rice 200 g, sea salt 2.5 g, distilled water 200 mL), which were inoculated with 10 mL of seed solution.Flasks were incubated at 25 o C under a day-night cycle.60 days old of fungal cultures from 40 flasks were subjected to organic extraction using Acetone /Ethyl acetate (EtOAc).The combined acetone/EtOAc fungal culture extracts were partitioned between 90% aqueous MeOH and petroleum ether.The resultant MeOH yield was fractionated using a silica column, Sephadex LH-20, and finally, semi-preparative reversed-phase HPLC to yield compounds (1-7).

. . NMR spectroscopy characterization
All the isolated compounds were checked for purity using Thin-layer Chromatography (TLC).After ensuring the purity, the compounds were subjected to 1 H and 13 C-Nuclear Magnetic Resonance (NMR) spectroscopy (500 MHz, Bruker).Trimethylsilane (TMS) was used as an internal standard.The NMR spectrum was analyzed using MestreNova spectral processing (Version.14.2.0).

. . Anticancer screening
Cytotoxicity was assessed using the Cell Counting Kit (CCK-8) (Dojindo, Japan) method adopted by Wang et al. (2015a).Cancer cell lines used in this study included K562, MCF-7, A549, HuH-7, H1975, HeLa, HL7702, DU145, HL60, MOLT-4.Additionally, a normal cell line, MCF10A, was included.All cell lines were procured from Shanghai Cell Bank, Chinese Academy of Sciences.Cells were routinely grown and maintained in RPMI or DMEM media with 10% Fetal Bovine Serum and 1% penicillin/streptomycin. Various concentrations of seven isolated compounds from Penicillium sp. were dissolved in 100% DMSO with a maximum concentration of 200 µg/mL and serially diluted to a final 0.1% DMSO concentration to treat cells for 2 h.Taxol was used as a positive control, and DMSO was used as a negative control.Cytotoxicity screening assay experiments were conducted in triplicate to obtain the standard error ± mean value.The percentage of cytotoxicity (IC 50 ) alongside the selectivity index was then calculated using the formula:

. . Anti-tuberculosis assay
The H37Ra strain of Mycobacterium tuberculosis (ATCC 25177) purchased from the American Type Culture Collection (ATCC) was used in the anti-TB bioassay.The anti-tuberculosis assay was based on the one used by Wang et al. (2015b).INH (Isoniazid) was used as the positive control, and DMSO was used as a negative control.For the minimum inhibitory concentration (MIC) analysis, 100 µl of Mycobacterium suspension was prepared in a 96-well microtiter plate.A total of 10 mL of double serial dilution of various concentrations of 7 isolated compounds (from 0.08 to 20 µg/mL) alongside the positive control isoniazid (1 to 417 µg/mL) was added to the well.The anti-tubercular assay was done in triplicate to obtain the SD± mean value.

. . Antiviral activity
Influenza A virus strains H1N1 (ATCC, VR-1520) and H3N2 (ATCC, VR-1679) were used in the present study.The antiviral activities against H1N1 and H3N2 were evaluated by the CPE inhibition assay based on the methodology (Fang et al., 2014).The IC 50 was determined by the concentration required to inhibit the influenza virus yield at 48 h post-infection by 50%.The antiviral assay was conducted in triplicate to obtain the SD± mean value.

. . Antimicrobial assay
The antimicrobial activities against Staphylococcus aureus (CGMCC 1.230) and Escherichia coli (CGMCC 1.2385) were evaluated by an agar dilution method based on the study by Wang et al. (2014).Microbial strains used in the present study were procured from the China General Microbiological Culture Collection Center (CGMCC).The isolated compounds were dissolved in dimethyl sulfoxide (DMSO) and added to a 96-well plate in a concentration ranging from 0.3 to 50 µg/mL.Then, malto broth liquid medium with grown bacterial suspension was added to each well, and the cell density was adjusted to ∼106 cfu/mL.The plates were kept in the incubator at 37 • C for 24 h.The minimum inhibitory concentrations (MIC) were denoted at least at a concentration where no microbial growth could be observed.Ciprofloxacin was used as a positive control, and DMSO was used as a negative control.The antimicrobial assay was done in triplicate to obtain the SD± mean value.

. . Data analysis
Each experimental data obtained after triplicate assays were computed as a standard error deviation.A p-value of ≤ 0.05 was calculated as statistically significant using a one-way ANOVA.The analysis was performed using SPSS statistical package version 19.0.

. . Molecular docking
Computational docking studies based on the structureactivity relationship obtain a better understanding of drug-target interactions.Based on the biological screening test compound (1), averufin was docked with four major cancer antigens of HL60 cell lines, namely, human serum transferrin, CD-5 antigen, CD-20, and alpha-beta tubulin from zinc-induced sheet based upon the methodology derived by Notarte et al. (2023).The antigenic drug targets were selected based on the previous literature survey and prominent antigens that are over-expressed on myeloid leukemia cancer cells (Taetle et al., 1985;Launder et al., 1996;Shariftabrizi et al., 2012;Lagorce et al., 2015).Taxol was used as a standard reference drug.Three dimensional (3D) structures of those target proteins human serum transferrin (1A8E), CD-5 antigen (2JOP), CD-20 (3BKY) antigen, and the refined structure of alpha-beta tubulin from zinc-induced sheets (1JFF), stabilized with taxol (PDB ID: 1A8E, 2JOP, 3BKY, and 1JFF, respectively) were retrieved from the protein data bank (PDB).The chemical structures of the natural inhibitors (taxol), as well as the averufin (1), were generated from SMILES notation (Simplified Molecular Input Line Entry Specification) using the Chemsketch Software.

. . Protein-ligand docking
For docking analysis, Argus Lab 4.0.1 software was used, followed in accordance to the methodology described by Duverna et al. (2010).The active sites on the target proteins were obtained from RCSB ligand explorer software.The proteins and ligands were geometrically optimized, and hydrogen bonds were added.The genetic algorithm (GA) was used as the docking engine, and the grid resolution was set to 0.40 A o .The calculation type was set to "Dock" mode, whereas "flexible mode" was selected for the ligand.The lowest energy represented the easy binding character of ligands and receptors.Molecular interactions between ligands and target proteins were visualized using Discovery Studio (Ver 3.1) software.

. . In-silico pharmacokinetic ADME predictions
The pharmacokinetic properties of compound (1) averufin were predicted by using the Swiss ADME software (Swiss Institute of Bioinformatics, 2019) based on the methodology derived by Quimque et al. (2021a).Pharmacokinetic ADME predictions were evaluated as Lipinski's "rule of five, " which includes the basic molecular weight, hydrogen bond acceptors and donors, and lipophilicity properties of the drug.The boiled egg prediction for compound (1) averufin was also assessed to check the water solubility.Apart from that, the OSIRIS property explorer program (Thomas Sander, Idorsia Pharmaceuticals Ltd., 2017) was employed for assessing the in-silico toxicity prediction to evaluate the mutagenicity, tumorigenicity, irritant effects, and reproductive toxicity efficacy of compound (1), i.e., averufin (de Leon et al., 2021;Quimque et al., 2021b;Brogi et al., 2022).

. . Molecular dynamic study
A molecular dynamic (MD) analysis was performed using Schrödinger maestro based on the methodology of Wu et al. (2018).Targets and ligands with maximum binding energy and clinical relevance based on docking results were selected and subjected to molecular dynamic drug target binding efficacy.Here, the target human serum transferrin (1A8E) protein was selected to dock with compound (1) averufin based on the good docking score.As a prerequisite for the dynamic studies, the parameters were fixed as the tetrahedron water box with water molecules were used to soak, and the edge of the box was 1 nm.Then, the surface charges of complexes were neutralized by adding 30 Na + and 10 Cl − .The energy minimization was conducted and equilibrated by NVT at 300 K and 1 bar for 100 ns and then subjected to a molecular dynamics study using an NPT ensemble.A molecular dynamic (MD) prediction of drug and target was performed at 100 nanoseconds (ns) to assess the bonding stability and displacement of ligand with that of the target.

. . Identification of fungi
Two-week-old fungal colonies reached a diameter of 2-3 cm wide.The colonies appeared pale green by visual observations.Under confocal microscopy (Leica Microsystems, Mannheim, Germany), the fungal hyphae stained with lactophenol blue appears to be slender with dispersed conidiophores (Figure 1).The fungal strain XWSO1F60 was identified as P. verruculosum based upon the sequence obtained from the internal transcribed spacer (ITS) regions (Genbank accession number: KU891245), and it has 99% similarity with that of P.verruculosum strain C2-8 (JQ717338) (Figure 2).

. . Metabolite isolation
The organic extract of P.verruculosum strain XWSO1F60 yielded seven different metabolites, which comprise polyketides, xanthones, and alkaloid derivatives.Structural determinations were carried out manually and referred to previously published NMR spectral data for their consistency (Figure 3).

. . Biological screening . . . Anticancer assay
Anticancer screening for all the seven compounds assessed using in-vitro methods revealed that compounds averufin (1) and methyl emodin (5) exhibit a significant anticancer effect against cancer cell lines compared to the others.Compound (1) shows strong anticancer activity toward HL60 cells with an IC 50 value of 1.005 µM concentration, and compound (5) shows moderate activity (Table 1).The rest of the compounds did not show any positive anticancer effects (data not shown due to any efficient activity).

. . . Antimicrobial, antiviral, and anti-tubercular assays
None of the tested compounds was recorded with any positive antimicrobial, anti-tuberculosis, or antiviral activity in the screening, except for anti-tuberculosis INH (Isoniazid), with a MIC value of 3.98µM, which was recorded.For antiviral, Tamiflu was used as the positive control with IC 50 values of 15.2 and 17.6nM, respectively, and for antimicrobial, ciprofloxacin was used as the positive control for S. aureus and E. coli with MIC values of 2.96 and 0.19µM, respectively.

. . . Molecular docking
Averufin (1) showed a better docking score when compared to the standard drug Taxol against all the target proteins, as evidenced by the protein-ligand interaction (Figure 4 and Table 2).The interacting amino acids present in the binding site and the hydrogen bonds are shown in Figure 4.The docking score ranged from −6.2627 to −10.2202 Kcal/mol.The best docking score of −9.0467 was observed against the 1A8E ligand, which corresponds to human transferring protein and is highly significant when compared to that of the Taxol drug.Since the protein 1JFF alpha-beta tubulin exerted a higher binding score of −10.2202Kcal/mol, which was also significantly higher than the standard Taxol (−8.93775Kcal/mol), the binding energy with 1A8E is very prominent.Similarly, averufin (1) showed quite a better docking hit against other target proteins.The docking study substantiates the in-vitro results.

. . . In-silico pharmacokinetic ADME predictions
Pharmacokinetic ADME predictions of averufin revealed considerable results for plausible drug properties.As per Lipinski's rule of five compound averufin has three hydrogen bond donors and seven hydrogen bond acceptors.The molecular weight, log P-value, and molar refractivity are within the acceptable limit of 368.34 g/mol, 2.98, and 93.40, respectively (Table 3).The Osiris pharmacokinetic analysis (Table 4) revealed that compound (1) averufin has no mutagenic, tumorigenic, and reproductive toxicity, which strongly support the consideration of this compound for future pharmacological screening for in-vivo experiments as this compound has a good drug score.The boiled egg simulation shows that the compound averufin (1) is hydrophilic, which is a good hallmark of its palatability in gastrointestinal digestion (Figure 5).Above all, the oral bioavailability of averufin is marked as well, both by Veber's and Egan's rules.This analysis revealed that all the pharmacokinetic parameters of averufin are within the permissible range for human use, which strongly suggests that averufin could be a potential drug-like molecule.

. . . Molecular dynamics study
Molecular dynamic results revealed the ligand-protein interaction stability over time.The root means square deviation (RMSD) analysis report states that the compound (1) averufin binds with the target protein (1A8E).At the arrival time of simulation, it displayed a steady state of around 0.15 ns to the completion until 100 ns, which is a hallmark for good drug target interaction stability without drug binding displacement from the 1A8E protein target domain (Figure 6A).The root means square fluctuation (RMSF) prediction for human transferrin protein (1A8E) flexibility is depicted in Figure 6B; it reveals that peaks indicate areas of the protein that fluctuate the most during the simulation.Typically, the protein tails (N-and C-terminal) fluctuate more than any other part of the protein.Secondary structure elements, such as alpha helices and beta strands, are usually more rigid than the unstructured part of the proteins and thus fluctuate less than the loop regions.Protein residues that interact with the ligand are marked with green-colored vertical bars, showing that the ligand interacts with protein maximum at 130-145 ns time scale (Figure 6C).The protein-ligand interaction studies show that the maximum interaction of ligand averufin of 71% takes place through its -OH functional groups that binds the target proteins with asparagine and glutamine amino acids, which was further confirmed from Figure 4.

. Discussion
Marine-derived natural products have seemingly attracted the interest of pharmacologists worldwide in recent years.Spongederived fungi account for the majority of the novel compounds (28%) reported from marine isolates of fungi (Hong et al., 2007;Hawas and El-Beih, 2012).Secondary metabolites derived from fungi are widely categorized as flavonoids, quinones, alkaloids, terpenoids, polyketides, isocoumarin derivatives, steroids, phenolic acids, and peptides with intriguing bioactive properties (Hajjaj et al., 2000;Ouyang, 2006;Zhang et al., 2009;Tian et al., 2015a,b).In the present study, seven different metabolites were isolated from the sponge-derived fungi P.verruculosum strain.Compounds (1-7) are of polyketide, quinone, and phenone derivatives.All seven isolated compounds were subjected to different biological assays, which include anticancer, antimicrobial, antiviral, and anti-tuberculosis screening.Compound (1) averufin exerts strong anticancer activity  et al., 2007).Compound (5), methyl emodin, exerts a weak anticancer effect against the tested cell lines.In a previous study, methyl-emodin tended to exert a moderate anticancer effect against the SGC-7901 cell line (Yang et al., 2009).Most of the compounds isolated herein have been reported from the P.verruculosum strain for the first time.Compound (2), a recently reported new compound from Aspergillus versicolor (Wu et al., 2016), is an interesting incidence and a first-time report from the P.verruculosum strain.
Molecular docking is a virtual technology that allows analyzing the precise drug-target interactions at the molecular level.With the advent of molecular docking studies, drug discovery and development have become convenient, especially for certain viral diseases like COVID-19 and Severe Acute Respiratory Syndrome (SARS) (Quimque et al., 2023).A plant-derived phenolic compound named Kobophenol-A binds with Spike protein receptors of both SARS-CoV-2 effectively, which were screened through virtual docking simulations, revealing that many natural can be a potential drug target for many viral diseases (Gangadevi et al., 2021).Since compound (1) averufin exerts a strong anticancer effect on the HL60 cell line, the antigenic targets of HL60 cell lines 1AE, 1JFF, 2JOP, and 3BKY were docked with averufin and the standard drug taxol.ADME-Tox prediction helps assess the drug and non-drug properties with a high probability of success or failure based on the drug mimickers for a molecule.Averufin was recorded with good binding energy, and its pharmacokinetic ADME pharmacokinetic analysis of averufin revealed that it is oral bioavailability and drug score based on OSIRIS and Lipinski rule, which are good indicators of drug validation in prospect.P.verruculosum, an endophytic fungus, has been reported to produce intriguing secondary metabolites and polyketide compounds with prominent anticancer activity.Monascorubrine and monascin are the groups of polyketide compounds from P. verruculosum that show considerable cytotoxic activity toward KA3IT cancer cells (Shah et al., 2014).The dynamic molecular study of compound (1) averufin with target protein 1A8E confirms that the drug-target interaction is good without any displacement up to 100 ns.A previous study on sulfonamidebenzoxazoles, a synthetic chemical drug was docked with HL-60 antigens, revealed that the drug showed the same interaction with minimal saturation (Oksuzoglu et al., 2017).Understanding how polyketide structural variation is generated is key to identifying new products encoded in the vast number of emerging sequenced microbial genomes and developing new bioactive polyketides through rational pathways or enzyme engineering (Crawford et al., 2010).The results indicate that averufin, an aromatic polyketide, is a potent tumor inhibitor against HL60, a human myeloid leukemia cell line, and it can be beneficial in the therapy of leukemic treatment in the future.The present study also highlights that sponge endophyte P. verruculosum is a promising source of natural bioactive compounds.

. Conclusions
In this study, we have evaluated the different metabolites isolated from sponge-derived fungi P.verruculosum.All of its structural characterization by NMR spectral studies speculate the chemical diversity of the fungus.Experimental results have shown the biomedical importance of isolated metabolites.Some of the isolated compounds have been reported from this fungus for the first time.The in-vitro and in-silico experimental findings of the compound averufin as a potent anticancer agent against leukemic HL-60 cell lines and its target antigens would also be helpful for researchers to conduct further in-vitro and in-vivo experimental studies for future applications.

FIGURE
FIGURE Sponge specimen and fungal colonies.(a): Sponge specimen S. o cinalis.(b): Fungal colony of P.verruculosum (XWSO F ) in the MB agar plate.(c, d): Hypha of the fungal colony after weeks under confocal microscopy imaging.Bars in both c and d represent µm.

FIGURE
FIGURE Depicting the molecular visualization of protein-ligand interactions.The interactions were visualized in Discovery Studio software.(A): A E and averufin.(B): JFF and averufin.(C): JOP and averufin.(D): BKY_chain-H and averufin.(E): BKY_chain-P and averufin.(F): A E and taxol.The dashed arrow shows the hydrogen bond.

FIGURE
FIGUREBoiled egg model to depict the gastrointestinal and blood-brain barrier solubility nature of compound averufin.

FIGURE
FIGURE(A-C) Molecular dynamic studies of compound Averufin with HL-antigen A E.
Fresh sponges of S. officinalis were collected from the Xidao Island (18o 23.18'N and 109 o 36.71'E),Hainan province of the South China Sea coast, in July 2014, during a marine cruise collection.Sponges were transported to the laboratory in ice-freeze conditions and stored at−20 o C until further use.Sponges were identified based on morphological and spicule identification by the Department of Marine Bioresources and Ecological Sciences, SCISO, China.A voucher specimen (Voucher Number: SCISO 45874/2018) was deposited at SCSIO marine biological collections.
TABLE Molecular docking score against the target proteins.
TABLE Lipinski rule-ADME validation for the compound averufin.
TABLE Osiris pharmacokinetic rule for the compound averufin.